Murat Bas

Summary

Country: Germany

Publications

  1. ncbi [Emergency management of acute angioedema]
    Murat Bas
    Hals, Nasen und Ohrenklinik, Klinikum rechts der Isar, Technische Universitat Munchen, Munchen
    Dtsch Med Wochenschr 135:1027-31. 2010
  2. ncbi Potential genetic risk factors in angiotensin-converting enzyme-inhibitor-induced angio-oedema
    Murat Bas
    Department of Otorhinolaryngology, Technische Universitat Munchen, Munchen, Germany
    Br J Clin Pharmacol 69:179-86. 2010
  3. ncbi [ACE-inhibitor induced angioedema]
    M Bas
    Hals Nasen Ohrenklinik und Poliklinik, Klinikum rechts der Isar der Technischen Universitat Munchen, Munchen, Germany
    Laryngorhinootologie 86:804-8, quiz 809-13. 2007
  4. ncbi [Angiotensin-converting enzyme inhibitor induced angioedema : new therapy options]
    M Bas
    Hals Nasen Ohrenklinik und Poliklinik, Klinikum rechts der Isar, Technische Universitat Munchen, Deutschland
    Anaesthesist 60:1141-5. 2011
  5. ncbi Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series
    Murat Bas
    Hals, Nasen und Ohrenklinik, Klinikum rechts der Isar, Technische Universitat Munchen, Ismaninger Strasse 22, Munich, Germany
    Ann Emerg Med 56:278-82. 2010
  6. ncbi Acute arterial hemorrhage following radiotherapy of oropharyngeal squamous cell carcinoma
    Jens Greve
    Department of Otorhinolaryngology, University of Duisburg Essen, Essen, Germany
    Strahlenther Onkol 186:269-73. 2010
  7. ncbi Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck
    Murat Bas
    Department of Otorhinolaryngology, University of Duesseldorf, Moorenstrasse 5, 40225 Duesseldorf, Germany
    Oral Oncol 42:691-7. 2006
  8. ncbi Successful long-term treatment with the bradykinin B2 receptor antagonist icatibant in a patient with hereditary angioedema
    Jens Greve
    Department of Otorhinolaryngology, University Hospital Essen, University Duisburg, Essen, Germany
    Int J Dermatol 50:1294-5. 2011
  9. ncbi Cyclin B1 expression and p53 status in squamous cell carcinomas of the head and neck
    Thomas K Hoffmann
    Department of Otorhinolaryngology, University of Duisburg Essen, Hufelandstrasse 55, 45147 Essen, Germany
    Anticancer Res 31:3151-7. 2011
  10. ncbi A novel mechanism for anti-EGFR antibody action involves chemokine-mediated leukocyte infiltration
    Thomas K Hoffmann
    Department of Otorhinolaryngology, Heinrich Heine University, Dusseldorf, Germany
    Int J Cancer 124:2589-96. 2009

Detail Information

Publications21

  1. ncbi [Emergency management of acute angioedema]
    Murat Bas
    Hals, Nasen und Ohrenklinik, Klinikum rechts der Isar, Technische Universitat Munchen, Munchen
    Dtsch Med Wochenschr 135:1027-31. 2010
    ..The following article gives an overview of the diagnostics and treatment in the emergency situation of "acute angioedema", especially if swelling of the head-and-neck region is present...
  2. ncbi Potential genetic risk factors in angiotensin-converting enzyme-inhibitor-induced angio-oedema
    Murat Bas
    Department of Otorhinolaryngology, Technische Universitat Munchen, Munchen, Germany
    Br J Clin Pharmacol 69:179-86. 2010
    ..We have investigated the impact of ACE insertion/deletion (I/D) polymorphism in combination with serum ACE activity as well as the bradykinin B2 receptor 2/3 and c.C181T polymorphisms...
  3. ncbi [ACE-inhibitor induced angioedema]
    M Bas
    Hals Nasen Ohrenklinik und Poliklinik, Klinikum rechts der Isar der Technischen Universitat Munchen, Munchen, Germany
    Laryngorhinootologie 86:804-8, quiz 809-13. 2007
    ..Typical sites of manifestation are lips, tongue, and larynx. Novel pharmacotherapies may allow a causal treatment of the ACE-inhibitor induced angioedema in the future...
  4. ncbi [Angiotensin-converting enzyme inhibitor induced angioedema : new therapy options]
    M Bas
    Hals Nasen Ohrenklinik und Poliklinik, Klinikum rechts der Isar, Technische Universitat Munchen, Deutschland
    Anaesthesist 60:1141-5. 2011
    ..A single subcutaneous injection of 30 mg icatibant resulted in a rapid onset of symptom relief and a remarkable shortening of duration of the attack...
  5. ncbi Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series
    Murat Bas
    Hals, Nasen und Ohrenklinik, Klinikum rechts der Isar, Technische Universitat Munchen, Ismaninger Strasse 22, Munich, Germany
    Ann Emerg Med 56:278-82. 2010
    ..We hypothesize that the bradykinin B2 receptor antagonist icatibant might be an effective therapy for ACEi-induced angioedema...
  6. ncbi Acute arterial hemorrhage following radiotherapy of oropharyngeal squamous cell carcinoma
    Jens Greve
    Department of Otorhinolaryngology, University of Duisburg Essen, Essen, Germany
    Strahlenther Onkol 186:269-73. 2010
    ..Vascular erosion is a rare but life-threatening complication after radiotherapy. The authors report on acute arterial bleeding and its therapy following radiotherapy of oropharyngeal tumors...
  7. ncbi Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck
    Murat Bas
    Department of Otorhinolaryngology, University of Duesseldorf, Moorenstrasse 5, 40225 Duesseldorf, Germany
    Oral Oncol 42:691-7. 2006
    ..The current study implies that increased frequencies of gamma/delta-T-cells in patients with SCCHN may not only be the result of tumor-host interactions but the consequence of applied treatment modalities...
  8. ncbi Successful long-term treatment with the bradykinin B2 receptor antagonist icatibant in a patient with hereditary angioedema
    Jens Greve
    Department of Otorhinolaryngology, University Hospital Essen, University Duisburg, Essen, Germany
    Int J Dermatol 50:1294-5. 2011
    ..It is characterized by recurrent subcutaneous or submucosal edema attacks in various organs with a frequency from a few attacks to over one hundred attacks per year...
  9. ncbi Cyclin B1 expression and p53 status in squamous cell carcinomas of the head and neck
    Thomas K Hoffmann
    Department of Otorhinolaryngology, University of Duisburg Essen, Hufelandstrasse 55, 45147 Essen, Germany
    Anticancer Res 31:3151-7. 2011
    ..We aimed to determine cyclin B1 expression in squamous cell carcinomas of the head and neck (SCCHN) and correlate it with p53 status and clinicopathological parameters...
  10. ncbi A novel mechanism for anti-EGFR antibody action involves chemokine-mediated leukocyte infiltration
    Thomas K Hoffmann
    Department of Otorhinolaryngology, Heinrich Heine University, Dusseldorf, Germany
    Int J Cancer 124:2589-96. 2009
    ..This novel mechanism for anti-EGFR mAb action may contribute to the antitumor effects of anti-EGFR mAb in vivo...
  11. ncbi Aberrant cytokine expression in serum of patients with adenoid cystic carcinoma and squamous cell carcinoma of the head and neck
    Thomas K Hoffmann
    Department of Otorhinolaryngology, Heinrich Heine University, D 40225 Dusseldorf, Germany
    Head Neck 29:472-8. 2007
    ..Our objective was to characterize and compare cytokine profiles in the systemic circulation of patients with SCC and ACC...
  12. ncbi Potential role of vasomotor effects of fibrinogen in bradykinin-induced angioedema
    Murat Bas
    Hals Nasen Ohrenklinik und Poliklinik, Klinikum rechts der Isar der Technischen Universitat Munchen, Munich, Germany
    J Allergy Clin Immunol 121:969-75.e2. 2008
    ..Although bradykinin is known to play a major role in the pathophysiology of hereditary and angiotensin-converting enzyme inhibitor (ACEi)-induced angioedema, other factors acting as triggers or enhancers are likely important as well...
  13. ncbi Rheumatic disorders affecting the head and neck: underestimated diseases
    Andreas Knopf
    Technische Universitat Munchen, Hals Nasen Ohrenklinik und Poliklinik, Munchen, Germany
    Rheumatology (Oxford) 50:2029-34. 2011
    ..To describe the clinical manifestations of rheumatic disorders with isolated head and neck (H&N) affection and to introduce a novel diagnostic pathway...
  14. ncbi Multimodal ultrasonographic characterisation of parotid gland lesions--a pilot study
    Andreas Knopf
    Technische Universitat Munchen, Hals Nasen Ohrenklinik und Poliklinik, Ismaningerstrasse 22, 81675 Munchen, Germany
    Eur J Radiol 81:3300-5. 2012
    ..The reliable pre-operative assessment of the lesional dignity might reduce patient's morbidity preventing re-surgery. To date, there exists no imaging technique which reliably distinguishes tumour entities...
  15. ncbi Aural myiasis in a patient with Alzheimer's disease
    Pascal Werminghaus
    Department of Otorhinolaryngology, Heinrich Heine University Dusseldorf, Moorenstrasse 5, Dusseldorf, Germany
    Eur Arch Otorhinolaryngol 265:851-3. 2008
    ..Aural manifestation of myiasis may become dangerous if the petrous bone is affected. Entomological aspects, clinical characteristics, and treatment of this rare disease are reviewed...
  16. ncbi T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx
    Thomas K Hoffmann
    Department of Otorhinolaryngology, University of Duesseldorf, Germany
    Int J Cancer 118:1984-91. 2006
    ....
  17. ncbi Nonallergic angioedema: role of bradykinin
    M Bas
    Hals, Nasen und Ohrenklinik, Universitatsklinikum Dusseldorf, Dusseldorf, Germany
    Allergy 62:842-56. 2007
    ..According to currently available reports, these drugs may improve the treatment of kinin-induced angioedema...
  18. ncbi Increased C-reactive protein in ACE-inhibitor-induced angioedema
    M Bas
    Department of Otorhinolaryngology, Heinrich-Heine University, , Germany
    Br J Clin Pharmacol 59:233-8. 2005
    ..CONCLUSION: Our findings demonstrate for the first time that ACEI-induced angioedema is associated with strongly increased plasma levels of CRP. We suggest that CRP is involved in the pathophysiology of ACEI-induced angioedema...
  19. ncbi Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant
    M Bas
    , Nasen- und Ohrenheilkunde, , Moorenstr. 5, , Germany
    Allergy 61:1490-2. 2006
  20. ncbi [Angioedema due to ACE inhibitors and AT(1) receptor antagonists]
    M-C Hellebrand
    Hals, Nasen- und Ohrenklinik,
    Hautarzt 57:808-10. 2006
    ..This medication also led to angioedema, which was not immediately recognized as medication-associated. AT(1)-receptor antagonists are not suitable alternatives for ACEi because they also carry an increased risk for inducing angioedema...
  21. ncbi [ACE inhibitor-induced angioedema in the head and neck region. A matter of time?]
    M Bas
    Hals Nasen Ohren Klinik, Universitatsklinikum Dusseldorf
    HNO 52:886-90. 2004
    ..So far, little is known about the time between the first application of ACEI and the occurrence of angioedema, or of possible cofactors and laboratory changes...